Recalls from Fresenius Kabi USA, LLC

• Tyenne (Tocilizumab-Aazg) Injection (opens in a new tab)
  High risk, FDA, Aug 10, 2026, Foreign object
• Fresenius Kabi Morphine Sulfate Injection (opens in a new tab)
  High risk, FDA, Aug 4, 2026, Labeling error
• Fresenius Kabi Glycopyrrolate, Lidocaine and Naropin Injections (opens in a new tab)
  Moderate risk, FDA, Jul 23, 2026, Foreign object
• Fresenius Kabi Epinephrine Injection (opens in a new tab)
  Low risk, FDA, Jun 5, 2026, Drug impurity
• Fresenius Kabi Ivenix Infusion System LVP Software (opens in a new tab)
  High risk, FDA, Jun 3, 2026, Software defect

Data: Recall Canary (opens in a new tab)